Oculometry as an Attentional Mechanism Evaluation Tool and Attention Deficit Hyperactivity Inhibition

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

60 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-05-05

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to analyse thanks to eye tracking experiments ocular movement classical parameters in children with attention deficit hyperactivity (ADH) and to compare them to results obtained in healthy children and to results obtained with neuropsychological tests commonly used in standard health care.

We should then be able to compare eye tracking with neuropsychological parameters.

The final objective is to give to health professional a tool for ADH investigation with which they should be able to do a simple and effective follow up of children with ADH.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Brain Activity Associated With Inhibition of Action in Attention-deficit

NCT04768556

Attention Deficit Hyperactivity Disorder

RECRUITING NA

NEUROFEEDBACK on Event-Related Potential (ERP)

NCT03289793

Attention Deficit Disorder With Hyperactivity

COMPLETED NA

Identification of Biomarkers of Attention Deficit Disorder With or Without Hyperactivity (ADHD) by a Metabolomic Approach in Children

NCT03436017

Adhd

COMPLETED

Role of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity

NCT02217371

Attention-Deficit/Hyperactivity Disorder

COMPLETED NA

Neural Mechanisms of Attention Lapses in Adult ADHD

NCT03948607

Attention Deficit Disorder Hyperactivity Disorder

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Attention Deficit-Hyperactivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Oculometric and neuropsychological tests

Oculometric tests and neuropsychological tests

Group Type EXPERIMENTAL

Neuropsychological tests

Intervention Type BEHAVIORAL

WISC test, BRIEF test, NEPSY-2 test, TAP2.3 test, Teach test

Oculometric tests

Intervention Type BEHAVIORAL

When the subject see a peripheric target, he should take a look not at the target but in the controlateral half-field, at a mirror position. This is called an anti-saccade task.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neuropsychological tests

WISC test, BRIEF test, NEPSY-2 test, TAP2.3 test, Teach test

Intervention Type BEHAVIORAL

Oculometric tests

When the subject see a peripheric target, he should take a look not at the target but in the controlateral half-field, at a mirror position. This is called an anti-saccade task.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children between 8 and 12 years old
* Boys and girls
* DSM-IV-TR diagnostic criteria for ADH
* Children with methylprednisone treatment
* Social security affiliation
* signed informed consent